ReviewCells2021
Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer.
Navid Sobhani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this papercites it
ReviewCells2021
Navid Sobhani et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.